Dr. Monica Kolinsky is the manager, alliance management PICI. In this role, she supports Weill Cornell Medicine scientists who participate in the collaboration between the institution and the Parker Institute for Cancer Immunotherapy and serves as the primary liaison to manage intellectual property matters pertaining to the consortium.
Prior to joining Weill Cornell Medicine, she worked as a corporate lawyer at Wiggin and Dana LLP in Connecticut where her practice focused primarily on life sciences and biotechnology transactional matters including licensing, corporate partnering and other technology transfer transactions. She also provided intellectual property-related support for due diligence matters, mergers and acquisitions, and litigation. In addition, Dr. Kolinsky worked at Grimes & Yvon LLP in New York, where she prepared and prosecuted patent applications in the areas of life sciences and biotechnology and negotiated agreements related to intellectual property. She was previously a licensing officer for Medical Research Council Technology (now known as LifeArc) in London, England and an associate and technology specialist at the law firm WilmerHale in New York.
Dr. Kolinsky holds a Ph.D. in Pharmacology from Weill Cornell Graduate School of Medical Sciences, and she earned her J.D. from New York Law School. She received her B.S. in Biology with a minor in Chemistry from Moravian College.
